TCL Archive “With resources now constrained, the ability of NCI to be responsive to its constituencies has been compromised.” July 7, 1995
TCL Archive Mysterious Group Urges Letters In Support Of Fisher, Calls For Investigation of NCI April 22, 1994
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment. September 28, 2001
